Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Gilead Sciences (GILD)
NASDAQ:GILD
Holding GILD?
Track your performance easily
See the Price Targets and Ratings of:
GILD Analyst Ratings
Moderate Buy
15 Buy
11 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
GILD Stock 12 Month Forecast
Average Price Target
$98.14
▲(5.75% Upside)
| Highest Price Target$125.00 | Average Price Target$98.14 | Lowest Price Target$73.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Bernstein
Reiterated
12/16/24
Truist Financial
Assigned
12/13/24
Piper Sandler
Assigned
12/12/24
Morgan Stanley
Assigned
12/11/24
RBC Capital
Reiterated
12/11/24
Deutsche Bank
Reiterated
12/11/24
Jefferies
Reiterated
12/11/24
Leerink Partners
Assigned
12/11/24
Wells Fargo
Assigned
12/10/24
Bank of America Securities
Initiated
12/10/24
J.P. Morgan
―
Buy
―
Reiterated
12/10/24
Gilead Sciences: Long-Term Growth Prospects in HIV Treatment Drive Buy Rating
Mizuho Securities
―
Buy
―
Assigned
12/10/24
Gilead Sciences' Anito-Cel Shows Promising Efficacy and Safety in Phase 2 Trial, Earning Buy Rating
Oppenheimer
$115
Buy
23.92%
Upside
Assigned
12/10/24
Gilead Sciences (GILD) PT Raised to $115 at OppenheimerOppenheimer analyst Hartaj Singh raised the price target on Gilead Sciences (NASDAQ: GILD) to $115.00 (from $105.00) while maintaining a Outperform rating.
HSBC
$69→$82
Hold
-11.64%
Downside
Reiterated
12/04/24
Gilead Sciences (GILD) PT Raised to $82 at HSBCHSBC analyst Rajesh Kumar raised the price target on Gilead Sciences (NASDAQ: GILD) to $82.00 (from $69.00) while maintaining a Hold rating.
Best Analysts Covering Gilead Sciences
Which Analyst Should I Follow If I Want to Buy GILD and Sell After:
1 Month
xxx
Success Rate
17/27 ratings generated profit
Average Return
+1.49%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 62.96% of your transactions generating a profit, with an average return of +1.49% per trade.
3 Months
xxx
Success Rate
17/27 ratings generated profit
Average Return
+2.90%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 62.96% of your transactions generating a profit, with an average return of +2.90% per trade.
1 Year
Success Rate
18/27 ratings generated profit
Average Return
+11.46%
reiterated a buy rating last month
Copying Tyler Van Buren's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +11.46% per trade.
2 Years
xxx
Success Rate
46/57 ratings generated profit
Average Return
+16.63%
reiterated a xxx
rating 7 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 80.70% of your transactions generating a profit, with an average return of +16.63% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
GILD Analyst Recommendation Trends
Rating
Aug 24
Sep 24
Oct 24
Nov 24
Dec 24
Strong Buy
1
0
0
0
0
Buy
26
21
26
31
36
Hold
28
29
28
27
24
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
55
50
54
58
60
Each month's total comprises the sum of three months' worth of ratings.
GILD Financial Forecast
GILD Stock Forecast FAQ
What is GILD’s average 12-month price target, according to analysts?
Based on analyst ratings, Gilead Sciences’s 12-month average price target is $98.14.
What is GILD’s upside potential, based on the analysts’ average price target?
Gilead Sciences has 5.75% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is GILD a Buy, Sell or Hold?
Gilead Sciences has a consensus rating of Moderate Buy which is based on 15 buy ratings, 11 hold ratings and 0 sell ratings.
What is Gilead Sciences’s price target?
The average price target for Gilead Sciences is $98.14. This is based on 26 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $125.00 ,the lowest forecast is $73.00. The average price target represents 5.75% Increase from the current price of $92.8.
The highest analyst price target is $125.00 ,the lowest forecast is $73.00. The average price target represents 5.75% Increase from the current price of $92.8.
What do analysts say about Gilead Sciences?
Gilead Sciences’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 26 Wall Streets Analysts.
How can I buy shares of GILD?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.